SRS Capital Advisors »

Lexicon Pharmaceuticals shares owned by SRS Capital Advisors

Quarter-by-quarter ownership of Lexicon Pharmaceuticals (LXRX) shares owned by SRS Capital Advisors from 13F filings

Historical chart of SRS Capital Advisors investment in Lexicon Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Lexicon Pharmaceuticals held by SRS Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexicon Pharmaceuticals by SRS Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.0k 639 1.57
2024-06-30 $1.1k 639 1.68

More positions owned by SRS Capital Advisors

Vanguard Index Fds Value Etf (VTV)
Ishares Tr Ishs 1-5yr Invs (IGSB)
Schwab Strategic Tr Us Tips Etf (SCHP)
Vanguard Index Fds Growth Etf (VUG)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core Us Aggbd Et (AGG)
Dimensional Etf Trust Core Fixed Incom (DFCF)
Vanguard Index Fds Mid Cap Etf (VO)
First Tr Exch Traded Fd Iii Pfd Secs Inc Etf (FPE)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Vanguard Index Fds Small Cp Etf (VB)
Ishares Tr S&p 500 Val Etf (IVE)

View all positions for SRS Capital Advisors

Top funds holding Lexicon Pharmaceuticals

Artal Group
Siren
OrbiMed Advisors
BlackRock
BlackRock
Vanguard Group
Geode Capital Management
NEA Management Company
State Street Corporation
Nantahala Capital Management
Schonfeld Strategic Advisors
Gail Mannix
Charles Schwab Investment Management
Point72 Asset Management
Woodline Partners

View all funds holding Lexicon Pharmaceuticals